Cervical cancer (CC) is the leading cause of cancer death among Peruvian women. Awareness shown by women living with HIV (WLHIV) of their increased risk and Papanicoloau (Pap) smear frequency is understudied, particularly in Peru. We assessed the uptake of guidelines-based CC screening practices and its associations with two predictors, knowledge of CC screening and risk and highly active antiretroviral therapy (HAART) adherence, among WLHIV. Collected by self-administered questionnaires from 2014 to 2016, we analyzed the data of 71 WLHIV. Most WLHIV (77.5%, n ¼ 55/71) were overdue to CC screening by not having a Pap smear within the prior 12 months. WLHIV who had on-time Pap smears had a higher median composite 'knowledge' score of 3.0 ([interquartile range] 1.5-4) compared to 2.0 (IQR 1-3) for overdue WLHIV. On-time and overdue WLHIV had the same median composite 'HAART adherence' score of 3.0 (IQR 2-4). Bivariate analysis found no association between knowledge nor adherence with on-time Pap smears. Although on-time WLHIV were more knowledgeable about CC screening and risk, overall CC screening uptake was poor. Larger studies of this population are needed to assess the educational, social, and structural barriers contributing to this low prevalence of screening.
Introduction
Cervical cancer (CC) is the leading cause of cancer death in Peruvian women. 1 Women living with HIV (WLHIV) are up to seven times more likely to develop CC than HIV-uninfected women 2 and often encounter social stigma when seeking healthcare. 3 Research in Peru to characterize uptake of CC screening has yet to focus on WLHIV. 4, 5 Although evolving, the Peruvian Ministry of Health 6 recommends WLHIV receive annual Papanicoloau (Pap) smears. This recommendation is also observed by the Centers for Disease Control and Prevention 7 who add that annual testing should follow two Paps within one year of HIV diagnosis. Potential predictors of CC screening practices include knowledge of risk 8, 9 and adherence to other health programs (i.e. highly active antiretroviral therapy [HAART] enrollment). This study will: (1) determine CC screening practices of WLHIV in Peru, (2) assess if knowledge of CC screening and risk and adherence to taking HAART are associated with CC screening practices.
Methods
Two studies conducted at Vı´a Libre, Lima's first nongovernmental organization to serve the HIV community, formed our dataset. One study was a baseline assessment from November to December 2014. The other evaluated attitudes towards mobile-based health services from December 2015 to March 2016. Neither had exclusion criteria for those 18 years old who provided written informed consent. Surveys were administered electronically for participants to self-report responses. Of 90 HIV-infected women surveyed, our study excluded 15 due to survey incompletion and 4 who received an HIV diagnosis 12 months prior to study enrollment. The Institutional Review Board at Vı´a Libre approved each study.
CC screening practice was judged as on-time if a Pap was obtained 12 months prior or as overdue if it occurred >1 year prior. Knowledge of CC screening and risk was assessed through four true/false questions. Adherence to HAART was assessed through four questions concerning missed dosages. A correct response was worth 1 point, leading to a score out of 4 for knowledge or adherence.
These scores were predictors for our outcome of CC screening practice, whether on-time or overdue. To test the association between categorical variables (each question) and the dichotomous outcome (CC screening practice), we used the Fisher's exact test. To test if the distribution of scores for knowledge or HAART adherence differed between each CC screening practice, we used the Wilcoxon rank sum test. We defined significance as p < 0.05 for all analyses, which were performed in Stata 14.0 (StataCorp, College Station, TX, USA).
Results
The mean age was 40.4 years old (range: 19-60). For annual Paps, 77.5% (n ¼ 55/71) of WLHIV were overdue including 12.7% (n ¼ 9/71) who had never had a Pap (Table 1) . Most overdue WLHIV (43.6%; n ¼ 24/ 55) had their last Pap one to two years prior. The median composite score for 'knowledge of CC screening and risk' was 3.0 (interquartile range [IQR] 1.5-4) for on-time and 2.0 (IQR 1-3) for overdue WLHIV. Bivariate analysis found no significant association between knowledge score and on-time Paps (Table 2) .
Overdue and on-time WLHIV had the same median composite score of 3.0 (IQR 2-4) for 'HAART adherence'. Though all were enrolled in an HAART program, 93.8% (n ¼ 15/16) of on-time WLHIV reported truly taking their medication as did 96.4% (53/55) of overdue WLHIV. Bivariate analysis found no significant association between HAART adherence and on-time Paps.
Discussion
We found that most WLHIV in the study were overdue for CC screening. On-time WLHIV had a higher median score for knowledge on CC screening and risk in comparison to overdue WLHIV, though an association was not found. This finding may be due to the limited size of our sample of Peruvian WLHIV. It can be seen that a greater proportion of on-time WLHIV answered a majority of knowledge questions correctly when compared to the answers of overdue WLHIV. This trend could precede finding a relationship between knowledge and seeking CC screening in a future larger study. Of upmost priority is the poor CC screening practice our study found. The HIV incidence in Peru is increasing faster in women than men. 11 The growth of this population alongside our results emphasizes the need for more WLHIV-specific research. This study is the first in Peru to survey an all HIV-infected sample of women to determine CC screening practice and if knowledge or HAART adherence were correlates, although neither group was more nor less adherent to HAART. Our results were drawn from a sample of WLHIV who attend an HIV clinic in Lima and may not be generalizable to all WLHIV in Peru. However, when universal barriers to screening are identified, effective methods to increase CC screening in gynecologic or integrated HIVgynecological care centers can aid in lowering CC among WLHIV.
